POAI - Predictive Oncology Inc Book Valuation of Business

This daily price chart for Predictive Oncology (POAI) on the GURU.Markets platform reflects a trend supported by the outsourcing of test system development and cloud computing, which is recorded at -0.34. High barriers to entry, driven by rare biomaterial collections, protect the company from predatory pricing. Long-term agreements with pharmaceutical behemoths to integrate AI models into drug discovery ensure a stable revenue stream.

POAI Predictive Oncology Corp Book Capitalization (07/04/2022 - 12/12/2025)

Predictive Oncology Corp (POAI) - metric breakdowns and financial figures

- price and consensus price forecast:

Stock Price Predictive Oncology|POAI - Analyst Consensus Forecast

- market capitalization data:

Market Capitalization Predictive Oncology Inc|POAI - Total Company Value

- book capitalization data:

Accounting Value per Share Predictive Oncology|POAI - Book Capitalization|Market-to-Book Ratio predictive-oncology.com|POAI - Company Total Assets

- debt and liquidity data:

Debt to Equity Ratio Predictive Oncology|POAI - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Predictive Oncology|POAI - Company Aggregate Debts|Debt to Book Value Predictive Oncology Inc

Fundamental valuation:POAI - Predictive Oncology Inc.

Mass-produced product of Predictive Oncology Inc.

Book value capitalization reflects the net value of a company's assets minus all liabilities, serving as an indicator of equity preservation and financial stability. By analyzing the book capitalization of Predictive Oncology (POAI), an investor can assess whether there are sufficient resources to develop the PeDAL AI platform to avoid value dilution amid the costs of developing oncology drugs.

Competitor analysis for Predictive Oncology